Search results
Exelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatments
GuruFocus.com via Yahoo Finance· 2 months agoExelixis Inc. (NASDAQ:EXEL) is a pharmaceutical company headquartered in Alameda, California that...
Biotech Stock Roundup: EXEL Partners RCUS for Study, PHVS & EYPT Gain on Study Data
Zacks via Yahoo Finance· 5 months agoIt was a busy week for the biotech sector, with numerous study readouts and other updates. Quite a...
Will Keytruda & Gardasil Aid Merck (MRK) Sales in Q4 Earnings?
Zacks via Yahoo Finance· 1 year agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor, Keytruda,...
Iovance's (IOVA) Meets Q3 Earnings, Lags Sales Estimates
Zacks via Yahoo Finance· 6 months agoIovance Biotherapeutics, Inc. IOVA incurred a loss of 46 cents per share in third-quarter 2023, in...
7 Myths About Kidney Cancer, Debunked
Time via Yahoo News· 1 year agodoctor holding orange ribbon. campaign to prevent skin cancer, melanoma, December orange Credit - Leonidas Santana—Getty Images Kidney cancer may well be...
Exelixis (EXEL) Announces Results From Phase II HNSCC Study
Zacks via Yahoo Finance· 2 years agoExelixis (EXEL) phase II study evaluating Cabometyx in combination with Keytruda in patients with...
Is Exelixis' (EXEL) Growth Story Likely to Continue?
Zacks via Yahoo Finance· 2 years agoExelixis EXEL, an oncology-focused company, maintains momentum on the back of the solid performance of its lead drug Cabometyx amid stiff competition...
Is Kidney Cancer Curable? Understanding the Odds
Verywell Health via Yahoo News· 3 months agoThere are several types of kidney (renal) cancer. Each type is potentially curable if it's found and treated early, before the cancer has a chance to...
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
Benzinga via Yahoo Finance· 1 year agoExelixis Inc (NASDAQ: EXEL) announced that the phase 3 CONTACT-03 study did not meet its primary...
Exelixis (EXEL) Collaborates With Arcus for Kidney Cancer Study
Zacks via Yahoo Finance· 5 months agoExelixis, Inc. EXEL entered into a clinical collaboration with clinical-stage company Arcus...